Investigation of the pharmacological mechanisms of Denglao Qingguan decoction in inhibiting viral pneumonia through network pharmacology and in vitro laboratory validation
Collectively, these findings indicate that DLQGD exhibits antiviral and anti-inflammatory activities, suggesting that it could be developed into a therapeutic constituent for respiratory viral infections.
Authors
- Biao Lei (ORCID: https://orcid.org/0000-0001-5255-2278)
- Ruihan Chen
- LinZhong Yu
- Xiannan Chen
- Bin Liu (ORCID: https://orcid.org/0000-0001-9295-8176)
- Shun Wang (ORCID: https://orcid.org/0009-0000-4428-9190)
- Qinhai Ma
- W M Lu
- Zhanyu Cui
- Ai Li
- Xuanxuan Li
- Fang Chen
- Xi Ren
Institutions
- Guangzhou University of Chinese Medicine (CN)
- State Administration of Traditional Chinese Medicine of the People's Republic of China (CN)
- First Affiliated Hospital of Guangzhou Medical University (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Maternal and Child Health Care Hospital of Bao'an (CN)
- TCM-Intigrated Cancer Center of Southern Medical University (CN)
- Guangdong Province Women and Children Hospital (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-01-12
- DOI
- https://doi.org/10.3389/fmed.2025.1708952
- Primary Topic
- Andrographolide Research and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China